KIRITSY CHRISTOPHER P
SEC Form 4 insider trading activity
KIRITSY CHRISTOPHER P has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Sep 4, 2026.
On the most recent filing, KIRITSY CHRISTOPHER P is listed as Director at PALVELLA THERAPEUTICS, INC. Inside the rolling window, KIRITSY CHRISTOPHER P reported no open-market purchases and 1 open-market sale totaling $49K in PVLA.
Companies traded
Other insiders at PVLA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$49K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has KIRITSY CHRISTOPHER P made?
KIRITSY CHRISTOPHER P has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does KIRITSY CHRISTOPHER P trade?
KIRITSY CHRISTOPHER P has filed SEC Form 4 disclosures for 1 company, including PVLA.
When was KIRITSY CHRISTOPHER P's most recent SEC Form 4 filing?
KIRITSY CHRISTOPHER P's most recent SEC Form 4 filing on Tracefour is dated Sep 4, 2026.
What is KIRITSY CHRISTOPHER P's total buy and sell value in the current window?
Inside the rolling retention window, KIRITSY CHRISTOPHER P bought $0 and sold $49K based on SEC Form 4 filings.
What was KIRITSY CHRISTOPHER P's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 313 PVLA shares on 2026-09-02, worth $49K, per SEC Form 4 filings.